Login
Koninklijke Philips (ADR) NYSE: PHG
Koninklijke Philips N.V. operates as a health technology company worldwide.
| Name | Koninklijke Philips (ADR) |
| Ticker | PHG |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Technology |
| Price | 54.22 |
| 52W Low/High | 31.86 / 56.03 |
| Market cap | 48 B |
| 1Y Total Return |
12.00%
Average |
| 1Y Volatility |
36.43%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Koninklijke Philips N.V. operates as a health technology company worldwide.
Details
| Ticker | PHG |
| Name | Koninklijke Philips (ADR) |
| ISIN | |
| CUSIP | |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Technology |
| Country | USA |
| Currency | U.S. Dollar |
Share as of 1/15/21
| Close Price | 54.22 |
| 52W Low/High | 31.86 / 56.03 |
| Market cap | 48 B |
| 1Y Total Return |
12.00%
Average |
| 1Y Volatility |
36.43%
Low Risk |
| Beta | 1.11 |
| PE (trailing) |
38.97
Above Average |
| 12M Dividends | 1.043478 |
| Last Dividend Date | 6/30/20 |
| Dividend Yield | 1.92% |
Fin. Strength
| Net Profit Margin | 6.0% |
| Cash from Op. / Cur. Liabilities | 0.29 |
| Diluted Earnings / Share | 1.39 |
| ROE | 9.2% |
| ROIC | 7.3% |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | 1.4 |
| Cur.Liabilities / Tot.Liabilities | 0.5 |
| Financial Leverage | 0.43 |
| in Mils USD |
rolling-year up to December
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Revenue |
21,176
|
20,592
|
21,789
|
26,136
|
26,730
|
24,253
|
|
| Gross Profit |
9,647
|
9,719
|
10,025
|
11,313
|
10,867
|
9,304
|
|
| R&D |
2,048
|
1,999
|
2,162
|
2,155
|
2,125
|
1,854
|
|
| EBITDA |
3,412
|
2,995
|
4,037
|
3,850
|
2,902
|
2,316
|
|
| Operating Income |
1,788
|
1,952
|
1,859
|
2,006
|
1,094
|
551
|
|
| Net Income exc. Extra |
1,268
|
1,239
|
2,031
|
1,544
|
711
|
471
|
|
| per Share | |||||||
| Diluted avg Shares |
-
|
-
|
-
|
-
|
-
|
-
|
|
| EPS exc. Extra |
1.39
|
1.32
|
2.14
|
1.66
|
0.77
|
0.51
|
|
| Dividend |
1.04
|
1.13
|
0.90
|
0.94
|
1.00
|
1.24
|
|
| Div. Yield (an.) |
2.07%
|
2.52%
|
1.92%
|
2.98%
|
3.62%
|
3.66%
|
|
| Balance Sheet | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Total Assets |
29,365
|
29,567
|
31,023
|
34,438
|
34,152
|
32,145
|
|
| Cash, Eq & Invt ShortTerm |
1,591
|
2,455
|
2,449
|
2,704
|
2,074
|
2,265
|
|
| Total Current Assets |
10,282
|
10,877
|
12,398
|
15,005
|
13,994
|
14,066
|
|
| Total Non-Current Assets |
19,084
|
18,690
|
18,625
|
19,433
|
20,158
|
18,079
|
|
| Intangibles |
13,174
|
13,741
|
13,545
|
13,273
|
13,469
|
11,934
|
|
| Total Liabilities |
15,642
|
15,798
|
16,289
|
20,037
|
21,164
|
19,710
|
|
| Total Current Liabilities |
7,585
|
9,026
|
8,414
|
11,165
|
11,100
|
10,461
|
|
| Long Term Debt |
8,058
|
6,772
|
7,875
|
8,872
|
10,064
|
9,248
|
|
| Shareholder equity |
13,692
|
13,736
|
14,705
|
13,434
|
12,858
|
12,321
|
|
| Cash Flow | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Cash from Operations |
2,208
|
2,023
|
2,292
|
2,030
|
1,287
|
1,477
|
|
| Depreciation |
1,524
|
1,238
|
1,256
|
1,351
|
1,412
|
1,346
|
|
| Cash from Investing |
-655
|
-1,689
|
-3,920
|
-1,244
|
-2,140
|
-1,116
|
|
| Capex |
1,957
|
1,670
|
1,548
|
1,657
|
1,723
|
1,698
|
|
| Cash from Financing |
-1,810
|
-1,355
|
67
|
-448
|
560
|
-1,348
|
|
| Stock Issued |
-1,433
|
-1,077
|
-509
|
-561
|
-469
|
-676
|
|
| Debt (LT) Issued |
118
|
182
|
-251
|
-402
|
1,357
|
-341
|
|
| Free Cash Flow |
73
|
1,758
|
923
|
788
|
2,040
|
2,279
|
|
| Ratios | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Net Profit Margin |
6.0%
|
6.0%
|
9.3%
|
5.9%
|
2.7%
|
1.9%
|
|
| NCFO / Op.Income |
123.5%
|
103.6%
|
123.3%
|
101.2%
|
117.6%
|
268.1%
|
|
| Current Ratio |
1.4
|
1.2
|
1.5
|
1.3
|
1.3
|
1.3
|
|
| Financial Leverage D/E |
0.43
|
0.40
|
0.39
|
0.45
|
0.50
|
0.38
|
|
| Return on Capital Avg |
7.3%
|
8.3%
|
10.3%
|
7.1%
|
3.5%
|
4.5%
|
|
| Return on Shareholder Equity |
9.2%
|
8.8%
|
14.6%
|
11.8%
|
5.5%
|
3.4%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available